Eventide Asset Management’s Global Blood Therapeutics, Inc. GBT Stock Holding History

Eventide Asset Management’s Portfolio GBT Stock Details GBT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-535,000	Closed	-$29.5M	–	170
2020 Q3	$29.5M	Hold	535,000	–	–	0.58%	59
2020 Q2	$33.8M	Hold	535,000	–	–	0.73%	49
2020 Q1	$27.3M	Hold	535,000	–	–	0.89%	44
2019 Q4	$42.5M	Hold	535,000	–	–	1.2%	35
2019 Q3	$26M	Hold	535,000	–	–	0.86%	44
2019 Q2	$28.1M	Buy	535,000 +168,000	+46%	+$9.65M	0.86%	41
2019 Q1	$19.4M	Hold	367,000	–	–	0.67%	58
2018 Q4	$15.1M	Buy	367,000 +137,000	+60%	+$5.13M	0.67%	52
2018 Q3	$8.74M	Buy	+230,000	New	+$10.2M	0.32%	81
2017 Q4	–	Sell	-190,000	Closed	-$5.9M	–	146
2017 Q3	$5.9M	Hold	190,000	–	–	0.33%	73
2017 Q2	$5.2M	Buy	190,000 +25,000	+15%	+$744K	0.32%	70
2017 Q1	$6.08M	Hold	165,000	–	–	0.4%	65
2016 Q4	$2.38M	Hold	165,000	–	–	0.16%	94
2016 Q3	$3.8M	Hold	165,000	–	–	0.23%	76
2016 Q2	$2.74M	Hold	165,000	–	–	0.17%	89
2016 Q1	$2.62M	Hold	165,000	–	–	0.15%	97
2015 Q4	$5.33M	Buy	165,000 +149,521	+966%	+$6.47M	0.27%	86
2015 Q3	$653K	Buy	+15,479	New	+$730K	0.04%	108

Other funds holding GBT

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

PAMU

Pictet Asset Management (UK) London, United Kingdom $91.8B AUM 47.77% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Eventide Asset Management's GBT Position: Q4 2020 in Review

Eventide Asset Management sold out of Global Blood Therapeutics, Inc. (GBT) in Q4 2020, closing a stake of 535,000 shares — an estimated $29.5M sold.

Eventide Asset Management first reported a position in GBT in Q3 2015 and held it in 18 quarters. The position peaked at $42.5M in Q4 2019. 228 funds tracked by Wall St. Rank hold GBT as of Q4 2020.

Eventide Asset Management reported no remaining Global Blood Therapeutics, Inc. position as of Q4 2020 after selling out during the quarter.
Eventide Asset Management sold 535,000 Global Blood Therapeutics, Inc. shares in Q4 2020, an estimated $29.5M.
Eventide Asset Management first reported a position in Global Blood Therapeutics, Inc. in Q3 2015 and held it in 18 quarters.
Eventide Asset Management's Global Blood Therapeutics, Inc. position peaked at $42.5M in Q4 2019.
228 funds tracked by Wall St. Rank held Global Blood Therapeutics, Inc. as of Q4 2020.

Based on Eventide Asset Management's 13F filing for Q4 2020, filed 16 Feb 2021.